TABLE 2.
Variable | Renal denervation (n = 11) | Spironolactone (n = 13) |
RAS blockers, n (%) | 11 (100) | 12 (92) |
α-blockers, n (%) | 6 (55) | 5 (39) |
β-blockers, n (%) | 6 (55) | 10 (77) |
Calcium-channel blockers, n (%) | 10 (91) | 9 (69) |
Diureticsa, n (%) | 11 (100) | 13 (100) |
Centrally acting drugs, n (%) | 2 (18) | 1 (8) |
RAS, renin–angiotensin system.
aOther than mineralocorticoid-receptor blockers.